This aim of this statement is to report an expert consensus on the diagnosis and treatment of
cardiac dysfunction in β-thalassemia major (TM). This consensus statement does not cover …

Abstract Carnitine (L-3-hydroxytrimethylamminobutanoate) is a naturally occurring
compound that can be synthesized in mammals from the essential amino acids lysine and …

In the last few years, cancer chemotherapy has been successfully employed in the treatment
of different types of human tumours. Unfortunately, the optimal clinical usefulness of this …

AIM: To evaluate the efficacy of L-carnitine on alleviating anemia, thrombocytopenia and
leukopenia, and minimizing dose reductions in patients with chronic hepatitis C virus (HCV) …

Anecdotal and experimental evidence suggest that the placebo effect is seen in athletics. To
this end, placebos have been used in clinical practice and athletic performance. Positive …

Background Mitochondrial fatty acid oxidation (FAO) disorders are among the causes of
acute encephalopathy-or myopathy-like illness. Carnitine–acylcarnitine translocase (CACT) …

Exercise performance is decreased in patients with Thalassemia major (TM), but the relative
impact of anemia and iron overload on exercise capacity is unknown. We assessed the …

Beta-thalassemia minor (BTM) patients usually experience fatigue, bone pain complaint,
and muscle weakness. Carnitine is an essential protein for transportation of long-chain fatty …

Beta-thalassemia is a genetic disorder characterized by the impaired synthesis of the
betaglobin chain of adult hemoglobin. The disorder has a complex pathophysiology that …

Patients with beta-thalassemia major (BTM) suffer from fatigue, poor physical fitness, muscle
weakness, lethargy, and cardiac complications which are related to an energy crisis …